Search Results

Filter
  • 1-10 of  38,008 results for ""Scleroderma, Systemic""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Induction of regulatory T cells and efficacy of low-dose interleukin-2 in systemic sclerosis: interventional open-label phase 1-phase 2a study.

  • Authors : Barde F; Service de médecine interne, AP-HP, Hôpital Saint Antoine, Sorbonne Universite, Paris, France.; Lorenzon R

Subjects: Interleukin-2*/Interleukin-2*/Interleukin-2*/adverse effects ; Interleukin-2*/Interleukin-2*/Interleukin-2*/therapeutic use ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/drug therapy

  • Source: RMD open [RMD Open] 2024 Apr 04; Vol. 10 (2). Date of Electronic Publication: 2024 Apr 04.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Survival in systemic sclerosis associated pulmonary arterial hypertension in the current treatment era-results from a nationwide study.

  • Authors : Sarı A; Department of Rheumatology, Etlik City Hospital, Varlık Neighborhood, Halil Sezai Erkut Street, 06170, Yenimahalle, Ankara, Turkey. .; Satış H

Subjects: Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/complications ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/mortality ; Pulmonary Arterial Hypertension*/Pulmonary Arterial Hypertension*/Pulmonary Arterial Hypertension*/drug therapy

  • Source: Clinical rheumatology [Clin Rheumatol] 2024 Jun; Vol. 43 (6), pp. 1919-1925. Date of Electronic Publication: 2024 Apr 27.Publisher: Springer Country of Publication: Germany NLM ID: 8211469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-9949

Record details

×
Academic Journal

Pulmonary Hypertension in Systemic Sclerosis.

  • Authors : Cullivan S; Department of Respiratory Medicine and Pulmonary Hypertension, National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland.; Cronin E

Subjects: Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/complications ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/physiopathology ; Hypertension, Pulmonary*/Hypertension, Pulmonary*/Hypertension, Pulmonary*/etiology

  • Source: Seminars in respiratory and critical care medicine [Semin Respir Crit Care Med] 2024 Jun; Vol. 45 (3), pp. 411-418. Date of Electronic Publication: 2024 Mar 26.Publisher: Thieme Medical Publishers Country of Publication: United States NLM ID: 9431858 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Application of blinatumomab, a bispecific anti-CD3/CD19 T-cell engager, in treating severe systemic sclerosis: A case study.

  • Authors : Subklewe M; Department of Medicine III - Hematology/Oncology, LMU University Hospital, LMU Munich, Munich, Germany; Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany

Subjects: Antibodies, Bispecific*/Antibodies, Bispecific*/Antibodies, Bispecific*/therapeutic use ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/drug therapy ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/immunology

  • Source: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Jun; Vol. 204, pp. 114071. Date of Electronic Publication: 2024 Apr 22.Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis.

  • Authors : Fairley JL; Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia; Department of Rheumatology, St. Vincent's Hospital Melbourne, Melbourne, Victoria, Australia. Electronic address: .

Subjects: Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/complications ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/physiopathology ; Ventricular Dysfunction, Left*/Ventricular Dysfunction, Left*/Ventricular Dysfunction, Left*/physiopathology

  • Source: Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2024 Jun; Vol. 66, pp. 152443. Date of Electronic Publication: 2024 Apr 06.Publisher: W.B. Saunders Country of Publication: United States NLM ID: 1306053 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A Prospective Observational Study of Disease Severity and Mortality in Hispanic American Patients With Systemic Sclerosis.

  • Authors : Jandali B; McGovern Medical School at the University of Texas Health Science Center at Houston.; Lyons M

Subjects: Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/mortality ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/ethnology ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/diagnosis

  • Source: Arthritis care & research [Arthritis Care Res (Hoboken)] 2024 Jun; Vol. 76 (6), pp. 768-776. Date of Electronic Publication: 2024 Mar 25.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Inflammatory Arthritis in Systemic Sclerosis: Its Epidemiology, Associations, and Morbidity.

Subjects: Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/epidemiology ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/complications ; Quality of Life*

  • Source: Arthritis care & research [Arthritis Care Res (Hoboken)] 2024 Jun; Vol. 76 (6), pp. 760-767. Date of Electronic Publication: 2024 Mar 04.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Managing gastrointestinal manifestations in systemic sclerosis, a mechanistic approach.

  • Authors : Kaniecki T; Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Hughes M

Subjects: Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/therapy ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/complications ; Gastrointestinal Diseases*/Gastrointestinal Diseases*/Gastrointestinal Diseases*/etiology

  • Source: Expert review of clinical immunology [Expert Rev Clin Immunol] 2024 Jun; Vol. 20 (6), pp. 603-622. Date of Electronic Publication: 2024 Feb 26.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101271248 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Fibroblast Subpopulations in Systemic Sclerosis: Functional Implications of Individual Subpopulations and Correlations with Clinical Features.

  • Authors : Zhu H; Department of Rheumatology and Immunology, Xiangya Hospital, Central South University, Changsha, China; Department of Internal Medicine 3, Friedrich-Alexander University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany

Subjects: Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/pathology ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/genetics ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/metabolism

  • Source: The Journal of investigative dermatology [J Invest Dermatol] 2024 Jun; Vol. 144 (6), pp. 1251-1261.e13. Date of Electronic Publication: 2023 Dec 24.Publisher: Elsevier Country of Publication: United States NLM ID: 0426720 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension.

  • Authors : Lui JK; The Pulmonary Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. .; Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. .

Subjects: Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/complications ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/drug therapy ; Scleroderma, Systemic*/Scleroderma, Systemic*/Scleroderma, Systemic*/physiopathology

  • Source: Cardiovascular drugs and therapy [Cardiovasc Drugs Ther] 2024 Jun; Vol. 38 (3), pp. 651-656. Date of Electronic Publication: 2023 Jan 06.Publisher: Kluwer Academic For The International Society For Cardiovascular Pharmacotherapy Country of Publication: United States NLM ID: 8712220 Publication

Record details

×
  • 1-10 of  38,008 results for ""Scleroderma, Systemic""